Dr. Martens (DOCS)

Down
Share Price:
484.80p
Market Cap:
4,848.00m
Change Today:
-13.80p
Sector:
Personal Goods

Dr Martens rated 'equal weight' by Barclays, 'outperform' by RBC

By Sean Farrell

Date: Thursday 11 Mar 2021

LONDON (ShareCast) - (Sharecast News) - Barclays and Royal Bank of Canada were both positive about Dr Martens as they started coverage but Barclays was more cautious about the boot maker's valuation.
Dr Martens is a popular brand with products loved by a broad range of consumers, Barclays said. Revenue and earnings have grown strongly over the past decade under private ownership and management has big ambitions, the bank added.

Barclays gave Dr Martens an 'equal weight' rating and a price target of 480p. The company's revenue and earnings prospects over the next three years justify a premium valuation but the shares have gained 27% since January's IPO.

Benchmarked against peers such as Canada Goose, Crocs and Deckers, Dr Martens' fair value is between 267p and 543p, Barclays said in a note to clients. With the shares at 456p at the time of publication that valuation looks on the high side, the bank said.

"We look for management to build a track record as a public company before arguing DOCS deserves to trade at the top of this range, Barclays said. "With FY21 results on 17 June, we see few near-term catalysts."

RBC initiated its coverage of Dr Martens, whose shoes have been worn by the Clash, the Specials and the Who, with an 'outperform' rating and a 550p price target. The brand represents "rebellious self-expression, a concept that is supported by cultural trends, RBC said. It sells lots of products direct to consumers, justifying high margins against its peers.

The group has opportunities to increase revenue in Asia Pacific, Europe, Middle East and Africa and the Americas, RBC said.

"DM has meaningful revenue growth prospects in the attractive branded footwear segment, and modest margin opportunity," RBC said. "We believe its strategic plan is tried and tested, underpinned by an established management team and strong brand momentum."

Dr Martens shares rose 0.8% to 459.8p at 12:47 GMT.



Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Price 484.80p
Change Today -13.80p
52 Week High 514.80p
52 Week Low 442.00p
Volume 575,478
Shares Issued 1,000.00m
Market Cap 4,848.00m

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
Not Available
Price Trend
market
  1. half market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Income
Not Available
Growth
Not Available
Price Chg 6m
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. half sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
P/E
Not Available
PEG
Not Available
Dividend Yield
Not Available
EPS Growth
Not Available
Operating Margin
Not Available